A real-world study conducted across 9 European countries found that bolus injection frequency and engagement with a smart pen to administer insulin were associated with improved glycemic control among ...
Please provide your email address to receive an email when new articles are posted on . Miller-Owen: Close to 8 million U.S. residents with diabetes are on insulin therapy, and the clear majority use ...
Mylan Pharmaceuticals has recalled some insulin-glargine injection pens because they may be missing labels. According to an announcement with the U.S. Food and Drug Administration, the lack of a label ...
One batch of Semglee prefilled insulin injection pens has been recalled by Mylan Pharmaceuticals for missing labels. Batch No. BF20003118, expiration August 2022 of Semglee (insulin glargine injection ...
Incorporating insulin into your daily life can take some getting used to. From packing your on-the-go bag to prepping your syringe or insulin pen, here are tips to get you started. Insulin may be one ...
Brown leatherette covered hinged case with gray flocked interior. Insets in interior hold a green and silver colored metal and plastic insulin pen. Interior of case also has insets to hold insulin ...
Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...
Rising Chronic Disease Burden, Biosimilar Insulin Adoption, and Smart Connected Pen Technologies Drive Sustained Market Expansion.Austin, United States, March 12, 2026 (GLOBE NEWSWIRE) -- As per SNS ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. What part of the phrase ‘risk of spreading blood-borne disease’ did the ...
Mylan Pharmaceuticals recalled one batch of Insulin Glargine Injection, 100 units/mL (U-100), 3 mL prefilled pens, which are sold in cartons of five. Some pens might be missing their labels. In ...
(RTTNews) - Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling certain Insulin Glargine (Insulin glargine-yfgn) Injection prefilled pens due to the potential for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results